Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Therapeutic Results in Patients with Hodgkin's Lymphoma Treated with Brentuximab Vedotin — Bulgarian Experience

Veselina S Goranova Marinova, MD PhD, Kalina Ignatova, MD, Penka Ganeva, MD, Emil Spasov, MD PhD, Ilina Micheva, MD PhD, Atanas Radinov, MD, Raya Petrova, MD, Gergana Tzvetkova, MD, Eugueni Hadzhiev, MD PhD, Stefan E Goranov, MD PhD DMSc, Liana Gercheva, MD PhD

Blood (2017) 130 (Supplement 1): 5193.

https://doi.org/10.1182/blood.V130.Suppl_1.5193.5193

Published: 2017

Journal Articles

Effect on Joint Health of Routine Prophylaxis with Bayer’s Sucrose-Formulated Recombinant Factor VIII (rFVIII-FS) in Adolescents and Adults Previously Treated on Demand: MRI Analyses from the 3-Year Spinart Study

Bjorn Lundin, Walter Hong, David Raunig, Sylvia Engelen, Charles Peterfy, Michael Werk, Marilyn J. Manco-Johnson, MD

Blood (2014) 124 (21): 2854.

https://doi.org/10.1182/blood.V124.21.2854.2854

Published: 2014

Journal Articles

Comparison of IgA Heavy/Light Chain Immunoassays with Capillary Zone Electrophoresis and Total Immunoglobulin Measurements

Lidia Gartcheva, Violeta Petkova, Keranka Dimitrova, Veronika Petkova, Penka Ganeva, Margarita Guenova

Blood (2014) 124 (21): 5692.

https://doi.org/10.1182/blood.V124.21.5692.5692

Published: 2014

Journal Articles

Immunoglobulin Heavy/Light Chain Measurements Provide Prognostic Information in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Lidia Gartcheva, Violeta Petkova, Keranka Dimitrova, Veronika Petkova, Penka Ganeva, Margarita Guenova

Blood (2014) 124 (21): 5693.

https://doi.org/10.1182/blood.V124.21.5693.5693

Published: 2014

Journal Articles

Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart

Jennifer Pocoski, PharmD, Benjamin Kim, MD MPhil, Thomas J. Humphries, MD, Walter Hong

Blood (2014) 124 (21): 1518.

https://doi.org/10.1182/blood.V124.21.1518.1518

Published: 2014

Journal Articles

Efficacy, PK and Safety Results of Clinical Study Of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) In Previously Treated Patients With Hemophilia B

Aaron Lubetsky, MD MSc, Toshko Lissitchkov, MD, Elena Santagostino, MD, PhD, Gantcho Jotov, MD, Tami Barazani-Brutman, Ph.D, Christine Voigt, Ph.D, Tina Moises, Ph.D, Iris C. Jacobs, MD, Uri Martinowitz, MD

Blood (2013) 122 (21): 1109.

https://doi.org/10.1182/blood.V122.21.1109.1109

Published: 2013

Journal Articles

Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Haemophilia B (PROLONG - 9FP)

Uriel Martinowitz, MD, Aaron Lubetsky, MD, Elena Santagostino, MD, PhD, Gantcho Jotov, MD, Jacob Luboshitz, MD, Shadan Lalezari, MD, Tami Barazani-Brutman, Ph.D, Christine Voigt, Ph.D, Tina Moises, Ph.D, Iris C. Jacobs, MD, Toshko Lissitchkov

Blood (2012) 120 (21): 1121.

https://doi.org/10.1182/blood.V120.21.1121.1121

Published: 2012

Journal Articles

Pregnancy as a Risk Factor for the Patients with Hodgkin Disease: Preliminary Report.

Janet G. Grudeva, MD, PhD

Blood (2009) 114 (22): 4636.

https://doi.org/10.1182/blood.V114.22.4636.4636

Published: 2009

Journal Articles

Chromosomal Abnormalities Detected by FISH in CLL May Be Influenced by Ethnic Origin: Preliminary Data from a Multicenter Study in Israel for the Israel CLL Study Group (ICLLSG).

Rosa Ruchlemer, MD, Lev Shvidel, MD, Andre A. Baester, MD, Osnat Bairey, MD, Alain Berrebi, MD, Aaron Polliack, MD

Blood (2007) 110 (11): 4705.

https://doi.org/10.1182/blood.V110.11.4705.4705

Published: 2007

Journal Articles

Prognostic Factors in Hodgkin’s Disease - Analysis of 211 Patients from a Single Institution.

Janet G. Grudeva, PhD, Ivanka Nenova, PhD, Nonka Mateva, PhD, Nikola Ananoshtev, Phd

Blood (2006) 108 (11): 4678.

https://doi.org/10.1182/blood.V108.11.4678.4678

Published: 2006

NARROW

Therapeutic Results in Patients with Hodgkin's Lymphoma Treated with Brentuximab Vedotin — Bulgarian Experience

Effect on Joint Health of Routine Prophylaxis with Bayer’s Sucrose-Formulated Recombinant Factor VIII (rFVIII-FS) in Adolescents and Adults Previously Treated on Demand: MRI Analyses from the 3-Year Spinart Study

Comparison of IgA Heavy/Light Chain Immunoassays with Capillary Zone Electrophoresis and Total Immunoglobulin Measurements

Immunoglobulin Heavy/Light Chain Measurements Provide Prognostic Information in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Regional Differences in Patient-Reported Outcomes in a Study of Adult Prophylaxis Versus on-Demand Treatment with Bayer’s Sucrose-Formulated Recombinant Factor VIII: 3-Year Data from Spinart

Efficacy, PK and Safety Results of Clinical Study Of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) In Previously Treated Patients With Hemophilia B

Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Haemophilia B (PROLONG - 9FP)

Pregnancy as a Risk Factor for the Patients with Hodgkin Disease: Preliminary Report.

Chromosomal Abnormalities Detected by FISH in CLL May Be Influenced by Ethnic Origin: Preliminary Data from a Multicenter Study in Israel for the Israel CLL Study Group (ICLLSG).

Prognostic Factors in Hodgkin’s Disease - Analysis of 211 Patients from a Single Institution.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only